PVLA
NASDAQ · Biotechnology
Palvella Therapeutics Inc
$116.23
-0.81 (-0.69%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
-54.6% upside
Low Target
$42.56
Average Target
$52.81
High Target
$76.13
Current Price
$116.23
Current
$116.23
$116.23
Target
$52.81
$52.81
$42.56
$52.81 avg
$76.13
Scenario Analysis
Bear Case
$42.56
-63.4%
Low target
Base Case
$52.81
-54.6%
Avg target
Bull Case
$76.13
+-34.5%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$114.69
1.3% from high
52-Week Low
$17.31
+571.5% from low
Target vs 52W High
$52.81
-54.0% vs high
Next Earnings Report
Apr 6, 2026 · After Market Close
10d
until earnings
EPS Est: $-0.93
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |